Hong Kong biomedical stocks rebounded sharply, Rongchang Bio (09995.HK) rose more than 9.5%, WuXi Bio (02269.HK) rose more than 7.5%, WuXi PharmaTech (02268.HK) rose more than 6%, WuXi PharmaTech (02359.HK), Junshi Biosciences (01877.HK) rose more than 5%, Konoya (02162.HK), Fuhong Hanlin (02696.HK) and so on.
Hong Kong biomedical stocks fell again in the afternoon, Junshi Biosciences (01877.HK), Kailaiying (06821.HK) fell more than 7%, Nuocheng Jianhua (09969.HK) fell more than 4.5%, drug combination (02268.HK), Tiger medicine (03347.HK), Kangfang biological (09926.HK) fell more than 3%.
Hong Kong stocks "drug" fell, drug combined (02268.HK) fell more than 10%, drug Kant (02359.HK) fell more than 5%, drug biological (02269.HK) fell more than 4%.
港股“药明系”普跌,药明合联(02268.HK)跌超10%,药明康德(02359.HK)跌超5%,药明生物(02269.HK)跌超4%。